Stockreport

MIRA Pharmaceuticals Announces Ketamir-2's Oral Bioavailability Predicted to be 80%

MIRA Pharmaceuticals, Inc.  (MIRA) 
PDF New Data from IQVIA Supports Potential $3 Billion Annual MarketBALTIMORE, Nov. 29, 2023 /PRNewswire/ -- MIRA Pharmaceuticals, Inc. (NASDAQ: MIRA) ("MIRA" or the "Company [Read more]